These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87. Excitatory amino acids and Alzheimer's disease: idle thoughts on an exciting subject. McGeer EG Neurobiol Aging; 1989; 10(5):614-6; discussion 618-20. PubMed ID: 2554171 [TBL] [Abstract][Full Text] [Related]
88. Pyramidal neurone modulation: a therapeutic target for Alzheimer's disease. Francis PT Neurodegeneration; 1996 Dec; 5(4):461-5. PubMed ID: 9117563 [TBL] [Abstract][Full Text] [Related]
89. Cholinergic neuromodulation and Alzheimer's disease: from single cells to network simulations. Menschik ED; Finkel LH Prog Brain Res; 1999; 121():19-45. PubMed ID: 10551018 [No Abstract] [Full Text] [Related]
90. Extra-pyramidal symptoms in Alzheimer's disease: a hypothesis. Horn D; Ruppin E Med Hypotheses; 1992 Dec; 39(4):316-8. PubMed ID: 1494318 [TBL] [Abstract][Full Text] [Related]
91. Human brain cholinergic pathways. Mesulam MM Prog Brain Res; 1990; 84():231-41. PubMed ID: 2267300 [No Abstract] [Full Text] [Related]
92. Pathogenesis of Alzheimer's disease--beyond the cholinergic hypothesis: discussion paper. Harrison PJ J R Soc Med; 1986 Jun; 79(6):347-52. PubMed ID: 2873250 [No Abstract] [Full Text] [Related]
93. The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease. Cacabelos R; Takeda M; Winblad B Int J Geriatr Psychiatry; 1999 Jan; 14(1):3-47. PubMed ID: 10029935 [No Abstract] [Full Text] [Related]